American Chemical Society
|Agreement labeling||Consortia Offset Benefit Program (COBP)|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2021 – 12/31/2023|
|Consortia / Institution||FinELib consortium|
Approximate range of annual corresponding author publications
|Comments on size/article output||Limited publishing allowed in the hybrid and fully open access journals but the number of articles is expected to cover the consortium output|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|If the open access articles designated for a certain year are not used completely they can be rolled over to the next year|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY mandatory|
||Original research articles
All peer reviewed journal articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
|Comments on access costs||Access-related costs are not possible to separate from publishing cost|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|